Growth Metrics

Adagio Medical Holdings (ADGM) Cash from Investing Activities (2023 - 2026)

Adagio Medical Holdings has reported Cash from Investing Activities over the past 4 years, most recently at -$2000.0 for Q1 2026.

  • Quarterly Cash from Investing Activities rose 99.4% to -$2000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$424000.0 through Mar 2026, up 60.63% year-over-year, with the annual reading at -$374000.0 for FY2025, 70.78% up from the prior year.
  • Cash from Investing Activities was -$2000.0 for Q1 2026 at Adagio Medical Holdings, down from $491000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $491000.0 in Q4 2025 and troughed at -$578000.0 in Q3 2024.
  • The 4-year median for Cash from Investing Activities is -$20000.0 (2023), against an average of -$86857.1.
  • Year-over-year, Cash from Investing Activities tumbled 106.79% in 2025 and then soared 99.4% in 2026.
  • A 4-year view of Cash from Investing Activities shows it stood at -$20000.0 in 2023, then tumbled by 2790.0% to -$578000.0 in 2024, then surged by 184.95% to $491000.0 in 2025, then tumbled by 100.41% to -$2000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Cash from Investing Activities are -$2000.0 (Q1 2026), $491000.0 (Q4 2025), and -$335000.0 (Q1 2025).